Home › Funds › MMCAP International Inc. SPC › CRDL
MMCAP International Inc. SPC position in CRDL
CARDIOL THERAPEUTICS INC · Health Care
MMCAP International Inc. SPC reported holding 15,598,560 shares of CRDL (CARDIOL THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$25.9M, representing 1.84% of its reported portfolio and ranking #5 among its reported holdings. MMCAP International Inc. SPC has disclosed CRDL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How MMCAP International Inc. SPC's CRDL position evolved
MMCAP International Inc. SPC first disclosed a stake in CRDL in Q3 2023 at 2,953,300 shares (US$2.64B). The position peaked in Q1 2024 at 2,566,125 shares, worth US$4.64B. Across 13 filings, MMCAP International Inc. SPC increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 15,598,560 shares valued at US$25.9M. Notable position changes include a 64% trim in Q2 2024 (shares fell 2% over the following quarter), a 63% trim in Q2 2025 (shares fell 21% over the following quarter), a 7247% increase in Q1 2026 (shares fell 21% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.95M | $2.64B | New |
| Q4 2023 | 2.95M | $2.66B | Hold |
| Q1 2024 | 2.57M | $4.64B | Reduce |
| Q2 2024 | 924.12K | $1.87B | Reduce |
| Q3 2024 | 795.62K | $1.58B | Reduce |
| Q4 2024 | 795.62K | $1.02M | Hold |
| Q1 2025 | 782.62K | $758.99K | Reduce |
| Q2 2025 | 293.06K | $398.56K | Reduce |
| Q3 2025 | 293.06K | $313.57K | Hold |
| Q4 2025 | 208.95K | $199.30K | Reduce |
| Q1 2026 | 15.35M | $20.73M | Add |
| Q2 2026 | 15.60M | $16.53M | Add |
| Q3 2026 | 15.60M | $25.89M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRDL and 13F data
CRDL (CARDIOL THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CRDL — the largest reported positions include Tejara Capital Ltd (US$12.3M), AIGH Capital Management LLC (US$166K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRDL
- Tejara Capital Ltd 7.42M sh · $12.32M · Q3 2026
- AIGH Capital Management LLC 100.00K sh · $166.00K · Q3 2026
More on MMCAP International Inc. SPC
FAQ
How long has MMCAP International Inc. SPC held CRDL?
MMCAP International Inc. SPC has disclosed CRDL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is MMCAP International Inc. SPC's current position in CRDL?
As of Q3 2026, MMCAP International Inc. SPC holds 15.60M shares of CRDL (CARDIOL THERAPEUTICS INC), valued at $25.89M, representing 1.84% of its reported portfolio and ranking #5.
Has MMCAP International Inc. SPC been buying or selling CRDL?
In the latest 13F filing (Q3 2026), MMCAP International Inc. SPC held unchanged its position in CRDL. The position peaked in Q1 2024 at 2.57M shares.
Which other funds hold CRDL?
Other major institutional holders of CRDL include Tejara Capital Ltd, AIGH Capital Management LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.